That is very important, since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work. In other words, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error process (jeff brown biotech stocks). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're created to do. This was a development almost nobody saw. However it's going to have extensive implications for treating disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of investment chances in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (tech stock). That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it drew back maybe considerably before going higher - brownstone research. I've been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mainly educating readers. However that's not the big question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff brown stock picks 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of fantastic private companies on the edge of striking the general public markets And I have actually been working on a new way for you to invest even prior to these business go public.
This opportunity has actually been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the information. Go right here to reserve your area for complimentary.
Emma Walsh here, handling editor of the Diary. Routine Diary readers understand that tech isn't our typical beat (jeff brown 1 biotech company). And when it concerns tech investing, we leave it to the professionals. Thankfully, we have several such specialists in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we know (jeff brown genetic sequencing stock). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These trends are experiencing rapid development and developing incredible opportunities for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown predictions for 2021. But in spite of what many readers may think, this is a pattern that's simply getting started. Although the COVID-19 pandemic disrupted supply chains last year, an outstanding 250 million 5G-enabled devices were still sold.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown top biotech stock 2021). Losing two months of manufacturing and sales truly impacts the number of 5G gadgets are offered in the fiscal year. When you consider all of that, selling 250 million units is amazing. More significantly, the hold-ups brought on by the pandemic created a lots of suppressed demand. Which need is now going to be pressed into 2021. In fact, I forecast that more than 500 million 5G devices will be delivered in 2021 - first lady. Which's not my only 5G forecast When I've discussed 5G in the past, I have actually described its three various phases.
In Stage 2, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services start to be used (legacy report prediction). That's when we begin to see applications running on 5G networks. Believe of things like massive multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage Three by this summertime. This starts something of a virtuous cycle: Many people do not truly care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open up a suite of extraordinary applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these innovations require 5G. The financial investment chances moving forward will be massive. Stepping away from 5G, the next essential technology I foresee in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not operate properly. CRISPR uses a similar concept however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For several years, CRISPR was primarily a niche technology that wasn't well comprehended. And throughout that time, there were truly only three companies running in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this technology simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This whole industry is effectively a greenfield opportunity.
There's room for numerous companies to exist in this area. brownstone research. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software application can accurately forecast the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That's important because the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has been an experimental procedure. However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but numerous drug therapies produced using this innovation. This was among those breakthroughs that nearly nobody observed. But it's going to have profound implications for treating disease. And, naturally, there will be plenty of investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps significantly prior to going higher. I have actually been covering bitcoin for a long time now. One of the first research study reports I ever published was on bitcoin - jeff bezos. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. biotech stocks. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the info is up to date since February 2021, however we might not independently confirm this claim. Given Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to pick winning technology stocks. He invested more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an outstanding viewpoint on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a number of his best choices in the Near Future Report.
That's high appreciation, however it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully forecasted some of the biggest financial events of the previous twenty years. Although he does not appear to release his choices to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it right each time, but Jeff Brown's precise predictions have made him legions of devoted fans. That states a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent financial research publisher. Brownstone Research study offers a number of research services with a wide array of specializations - exponential growth.
The business is also associated with Bonner & Partners, another well-respected research study publisher - social media. On its website, Brownstone states its mission is to supply retail investors with professional-grade research study: "For too long, the finest investment research has not been offered to specific financiers. It has been generally reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. last week. The mission of Brownstone Research study is to make that sort of proprietary research study readily available to any investors seeking to acquire an edge in the markets. The goal is easy to provide unique and profitable investment research discovered nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise works as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After years of stable success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout the majority of America. If you know even a bit about the market, you know that he has a track record as a King Midas of sorts. brownstone research. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. brownstone research. might be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying two advanced technologies: artificial intelligence and electrical cars. Musk hopes the mix will assist him develop the first fully-autonomous, self-driving cars and trucks ever. It's nothing brief of the automobile industry's Holy Grail. As you know, electrical cars and self-driving car stocks have been big this year, however the Wall Street machine has approved hype without much tangible result. Despite a drastic boost in competitors over the past few years, Brown still believes Musk has the finest opportunity of putting it all together.
tech might be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Vehicle, and it could be the future of transportation. Essentially, this technology would permit you to rent your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You just leave the automobile and press a button on an app that informs the automobile to "join the fleet." Next thing you know, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a large chunk of the revenues. It sounds insane, however it might be closed than you believe.